Schizophrenia Research
Volume 115, Issue 2 , Pages 97-103, December 2009

Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: An open randomized clinical trial (EUFEST)

  • Han Boter

      Affiliations

    • Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Utrecht, The Netherlands
    • Corresponding Author InformationCorresponding author. Department of Epidemiology (room FA 40), University Medical Centre Groningen, PO Box 30001, NL - 9700 RB Groningen, The Netherlands. Tel.: +31 50 3611808; fax: +31 50 3614493.
  • ,
  • Joseph Peuskens

      Affiliations

    • University Psychiatric Centre, Campus St. Jozef Kortenberg, Katholieke Universiteit Leuven, Leuven, Belgium
  • ,
  • Jan Libiger

      Affiliations

    • Department and Clinic of Psychiatry, Charles University Medical School and Faculty Hospital, Hradec Králové, Czech Republic
  • ,
  • W. Wolfgang Fleischhacker

      Affiliations

    • Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck, Austria
  • ,
  • Michael Davidson

      Affiliations

    • Sheba Medical Center, Tel Hashomer, Israel
  • ,
  • Silvana Galderisi

      Affiliations

    • Department of Psychiatry, University of Naples SUN, Naples, Italy
  • ,
  • René S. Kahn

      Affiliations

    • Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Centre Utrecht, Utrecht, The Netherlands
  • ,
  • for the EUFEST study group

Received 3 March 2009; received in revised form 3 August 2009; accepted 16 September 2009. published online 12 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0920-9964(09)00438-1

doi:10.1016/j.schres.2009.09.019

Schizophrenia Research
Volume 115, Issue 2 , Pages 97-103, December 2009